Sonova Group broadens portfolio of hearing solutions with launch of Sona

By launching Sona, the Sonova Group is introducing a novel business concept combining a specialized product portfolio with easy fitting and simplified logistic processes, which are unique in the industry. The new brand broadens the portfolio of the established hearing solutions of Phonak and Unitron and is aimed at the market segment for mild-to-moderate hearing loss. It features mainly the integrated service concept providing audiologists with new opportunities to make their hearing solutions more accessible to consumers.

“Consumers benefit from the immediate availability of tailored hearing solutions and straightforward access to their first experience of improved hearing – a key factor in successful fitting and in the subsequent decision to buy.”

“With Sona products, we are offering hearing specialists optimized and simplified online ordering and storage processes that are unique within our industry,” said Valentin Chapero, CEO of the Sonova Group. “Consumers benefit from the immediate availability of tailored hearing solutions and straightforward access to their first experience of improved hearing – a key factor in successful fitting and in the subsequent decision to buy.”

Two types of products are available under the new brand: “Sona:vogue micro” is a high-tech device worn behind the ear and “Sona:vogue intro” is the corresponding in-the-ear solution. Both product types are available in three different price/performance categories.

Following its successful roll-out onto the Belgian market, Sona will now be launched progressively in selected European countries and in the US.

Source Sonova

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Low-dose aspirin does not affect the progression of age-related hearing loss